Article Versions Notes

Chuang C-H, Chen H-L, Chang H-M, Tsai Y-C, Wu K-L, Chen I-H, Chen K-C, Lee J-Y, Chang Y-C, Chen C-L, et al. Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer. Cancers. 2021; 13(8):1966. https://doi.org/10.3390/cancers13081966

Chuang, Cheng-Hao, Hsiao-Ling Chen, Hsiu-Mei Chang, Yu-Chen Tsai, Kuan-Li Wu, I-Hua Chen, Kung-Chao Chen, Jui-Ying Lee, Yong-Chieh Chang, Chin-Ling Chen, and et al. 2021. "Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer" Cancers 13, no. 8: 1966. https://doi.org/10.3390/cancers13081966

Chuang, C.-H., Chen, H.-L., Chang, H.-M., Tsai, Y.-C., Wu, K.-L., Chen, I.-H., Chen, K.-C., Lee, J.-Y., Chang, Y.-C., Chen, C.-L., Tu, Y.-K., Hung, J.-Y., Yang, C.-J., & Chong, I.-W. (2021). Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer. Cancers, 13(8), 1966. https://doi.org/10.3390/cancers13081966